Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02245789Completed
Randomised, single-blind trial (2 arms), sponsored by Hôpital Foch. Primary endpoint: Required dose of opioid to counteract nociceptive stimulation at 1 hour. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02245789.